Clinical Translational Science Institute Director of Investor Relations Salaries in Wilmington, DE
The average Clinical Translational Science Institute Director of Investor Relations in Wilmington, DE earns an estimated $204,711 annually. Clinical Translational Science Institute's Director of Investor Relations compensation is $62,182 more than the US average for a Director of Investor Relations.
In Wilmington, DE, The Communications Department at Clinical Translational Science Institute earns $10,940 more on average than the Engineering Department.
Last updated 5 years ago.
- $204,711
- avg. base
Director of Investor Relations Salaries at Clinical Translational Science Institute
In Wilmington, DE, Directors of Investor Relations earn $46,513 more than Directors of PR.
Compensation at Clinical Translational Science Institute by Department
In Wilmington, DE, The Communications Department averages $10,940 more than the Engineering Department, and $801 less than the Product Department
How Directors of Investor Relations at Clinical Translational Science Institute Rate Their Compensation
The majority of Directors of Investor Relations at Clinical Translational Science Institute believe they're compensated fairly. 100% of Directors of Investor Relations at Clinical Translational Science Institute say they receive annual bonuses. See more compensation ratings at Clinical Translational Science Institute
